BGLC Key Financial Ratios - BioNexus Gene Lab Corp

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	6.08	—	-29.51%	-33.11%
2026-03-31	6.52	—	-32.13%	-35.89%
2025-12-31	10.46	—	-32.26%	-34.64%
2025-09-30	8.3	—	-30.14%	-33.70%
2025-06-30	3.63	—	-31.13%	-38.99%
2025-03-31	4.19	—	-22.34%	-27.25%
2024-12-31	3.81	—	-15.32%	-19.20%
2024-09-30	4.98	—	-8.56%	-10.03%
2024-06-30	5.6	—	-19.80%	-23.10%
2024-03-31	4.61	—	-23.87%	-28.51%
2023-12-31	4.93	—	-23.06%	-27.22%
2023-09-30	—	—	—	-33.22%
2023-06-30	2.79	—	-7.12%	-10.06%
2023-03-31	3.49	—	-5.40%	-7.15%
2022-12-31	3	—	-4.07%	-5.34%
2022-09-30	4.05	—	-1.41%	-1.71%
2022-06-30	3.84	—	3.14%	3.85%
2022-03-31	3.33	—	4.69%	6.03%
2021-12-31	3.07	—	7.85%	10.47%
2021-09-30	2.78	—	5.00%	6.92%
2021-06-30	2.76	—	4.52%	6.27%
2021-03-31	2.49	—	3.67%	5.35%
2020-12-31	2.37	—	10.82%	16.42%
2020-09-30	18.87	—	116.03%	17.59%
2020-06-30	16.42	—	86.70%	14.83%
2020-03-31	17.06	—	78.50%	14.29%
2019-12-31	17.11	—	-20.02%	-21.96%
2019-09-30	37.5	—	-16.13%	-17.16%
2019-06-30	18.25	—	-18.76%	-20.42%
2019-03-31	18.88	—	-15.73%	-17.11%
2018-12-31	20.64	—	4.87%	5.29%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	10.46	—	-32.26%	-34.64%
2024-12-31	3.81	—	-15.32%	-19.20%
2023-12-31	4.93	—	-23.06%	-27.22%
2022-12-31	3	—	-4.07%	-5.34%
2021-12-31	3.07	—	7.85%	10.47%
2020-12-31	2.37	—	10.82%	16.42%
2019-12-31	17.11	—	-20.02%	-21.96%
2018-12-31	20.64	—	1.60%	1.74%